Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Parkinson's Disease (PD)”

51 trials

Showing 20 of 51 results

Testing effectiveness (Phase 2)Study completedNCT05931575
What this trial is testing

Safety, Tolerability and Symptomatic Efficacy of the ROCK-Inhibitor Fasudil in Patients With Parkinson's Disease

Who this might be right for
Idiopathic Parkinson´s Disease
Technical University of Munich 81
Large-scale testing (Phase 3)Study completedNCT01227655
What this trial is testing

Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients.

Who this might be right for
Parkinson's Disease
Bial - Portela C S.A. 427
Testing effectiveness (Phase 2)Study completedNCT02462603
What this trial is testing

Safety and Biomarker Study of PTC-589 in Participants With Parkinson's Disease

Who this might be right for
Parkinson's Disease
Edison Pharmaceuticals Inc 44
Not applicableStudy completedNCT05795023
What this trial is testing

A Longitudinal Evaluation of Oculometric Measures and Clinical Assessment Over Time in PD Patients

Who this might be right for
Parkinson Disease
NeuraLight 30
Not applicableLooking for participantsNCT07337226
What this trial is testing

Association of VAgus Nerve Stimulation and Treadmill Training for GAit Rehabilitation in DE Novo Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease (PD)
Fondazione Policlinico Universitario Campus Bio-Medico 60
Early research (Phase 1)Looking for participantsNCT07195825
What this trial is testing

A Clinical Study to Evaluate the Safety, and Tolerability of BBM-P002 in the Treatment of Parkinson's Disease

Who this might be right for
PD
Shanghai Xinzhi BioMed Co., Ltd. 18
Large-scale testing (Phase 3)Study completedNCT01286935
What this trial is testing

18-month Study of Long-term Efficacy & Safety of Safinamide as add-on Therapy in Patients With Mid-late Stage PD

Who this might be right for
Parkinson's Disease
Newron Pharmaceuticals SPA 544
Early research (Phase 1)Looking for participantsNCT07840027
What this trial is testing

Assessment of the Safety, Immunogenicity, and Pharmacodynamics of TRB-001 in Patients With Early Idiopathic Parkinson's Disease

Who this might be right for
Parkinson Disease (PD)Idiopathic Parkinson's Disease
Tridem Bioscience FlexCo 36
Large-scale testing (Phase 3)Study completedNCT02240030
What this trial is testing

Efficacy and Safety Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes

Who this might be right for
Idiopathic Parkinson's Disease
Acorda Therapeutics 351
Not applicableStudy completedNCT03944785
What this trial is testing

Clinical Outcome Assessment of Parkinson's Disease Patients Treated With XADAGO (Safinamide)

Who this might be right for
Idiopathic Parkinson Disease
Supernus Pharmaceuticals, Inc. 164
Large-scale testing (Phase 3)Study completedNCT01187966
What this trial is testing

Efficacy and Safety of Safinamide (50 and 100mg/Day) Versus Placebo, in Patients With Mid-late Stage Parkinson's Disease

Who this might be right for
Parkinson's Disease
Newron Pharmaceuticals SPA 669
Not applicableLooking for participantsNCT06814431
What this trial is testing

Study on the Incidence of Malignant Neoplasms in Patients With Parkinson's Disease and Heterozygous Mutation of the GBA Gene

Who this might be right for
Idiopathic Parkinson's Disease (PD)
Azienda USL Reggio Emilia - IRCCS 3,000
Not applicableLooking for participantsNCT06859528
What this trial is testing

Step Up to PD: A Community-based Walking Program for People With Parkinson's Disease

Who this might be right for
Parkinson DiseaseParkinson Disease, Idiopathic
St. Louis University 40
Early research (Phase 1)UnknownNCT00674895
What this trial is testing

Far Infrared Irradiation for Management and Treating of Parkinson's Disease (PD)

Who this might be right for
Parkinson's Disease
GAAD Medical Research Institute Inc. 10
Testing effectiveness (Phase 2)Study completedNCT01113320
What this trial is testing

Safinamide in Levodopa Induced Dyskinesia in Parkinson's Disease Subjects

Who this might be right for
Parkinson's Disease
Newron Pharmaceuticals SPA 26
Post-approval studies (Phase 4)UnknownNCT01007630
What this trial is testing

A Study Assessing Change in Sense of Smell After Rasagiline Use in Parkinson's Patients

Who this might be right for
Parkinson's Disease
The Parkinson's Institute 36
Not applicableStudy completedNCT04504422
What this trial is testing

TDCS for Dual-task Performance in Patients With PD

Who this might be right for
Parkinson Disease
Seoul National University Hospital 24
Not applicableUnknownNCT02250690
What this trial is testing

Neuromodulation on Motor Function in Parkinson's Disease

Who this might be right for
Idiopathic Parkinsons Disease
Universidade Federal de Pernambuco 24
Testing effectiveness (Phase 2)Study completedNCT01211587
What this trial is testing

A Trial to Explore the Potential Benefit of Safinamide on Cognitive Impairment Associated With Parkinson's Disease

Who this might be right for
Parkinson's Disease With Cognitive Impairments
Newron Pharmaceuticals SPA 103
Post-approval studies (Phase 4)Study completedNCT00594464
What this trial is testing

A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery

Who this might be right for
Parkinson's Disease
UCB Pharma 14
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation